CYP2D6

Results: 88



#Item
1Beilage 1: Arzneimittelmonographien

Beilage 1: Arzneimittelmonographien

Add to Reading List

Source URL: www.sscc.ch

Language: English - Date: 2007-04-18 04:07:44
2Beilage 1: Arzneimittelmonographien

Beilage 1: Arzneimittelmonographien

Add to Reading List

Source URL: www.sscc.ch

Language: English - Date: 2007-04-18 04:07:36
3Beilage 1: Arzneimittelmonographien

Beilage 1: Arzneimittelmonographien

Add to Reading List

Source URL: www.sscc.ch

Language: English - Date: 2007-04-18 04:07:43
4Beilage 1: Arzneimittelmonographien

Beilage 1: Arzneimittelmonographien

Add to Reading List

Source URL: www.sscc.ch

Language: English - Date: 2007-04-18 04:07:35
5Seven considerations when evaluating pharmacogenetic testing in workers’ compensation Claimants, as unique individuals, may respond differently to a prescribed therapy. After an equal dose of the same medication, Claim

Seven considerations when evaluating pharmacogenetic testing in workers’ compensation Claimants, as unique individuals, may respond differently to a prescribed therapy. After an equal dose of the same medication, Claim

Add to Reading List

Source URL: helioscomp.com

Language: English - Date: 2016-07-07 08:49:30
6The influence of the CYP2D6*4 polymorphism on drug response and disease susceptibility Monique Johanna Bijl The Rotterdam Study is supported by the Erasmus Medical Center and Erasmus University

The influence of the CYP2D6*4 polymorphism on drug response and disease susceptibility Monique Johanna Bijl The Rotterdam Study is supported by the Erasmus Medical Center and Erasmus University

Add to Reading List

Source URL: nvza.nl

Language: English
    7Chapter 4. Pharmacogenetics and Pharmacogenomics Kim Brøsen, M.D., Ph.D. Institute of Public Health Clinical Pharmacology University of Southern Denmark

    Chapter 4. Pharmacogenetics and Pharmacogenomics Kim Brøsen, M.D., Ph.D. Institute of Public Health Clinical Pharmacology University of Southern Denmark

    Add to Reading List

    Source URL: www.iuphar.org

    Language: English - Date: 2005-11-24 01:13:00
    8Validation of Mechanism Based Inhibition: Our Experience Franca Pugnaghi, Craig Thomas, Rachael Brown and Peter Fenn Aptuit Limited, Riccarton, Edinburgh EH14 4AP, UK

    Validation of Mechanism Based Inhibition: Our Experience Franca Pugnaghi, Craig Thomas, Rachael Brown and Peter Fenn Aptuit Limited, Riccarton, Edinburgh EH14 4AP, UK

    Add to Reading List

    Source URL: www.aptuit.com

    Language: English - Date: 2015-02-05 10:57:53
    92D6-2C9-2C19 Website.xls CYP2D6 Genotype2 Genotype2

    2D6-2C9-2C19 Website.xls CYP2D6 Genotype2 Genotype2

    Add to Reading List

    Source URL: wwwn.cdc.gov

    Language: English - Date: 2013-02-13 14:52:12
    10Reference Materials NOT Previously Characterized (CYP 2D6, 2C9 and CYP2C19 Alleles) CYP2C9 CYP2D6 Genotype2

    Reference Materials NOT Previously Characterized (CYP 2D6, 2C9 and CYP2C19 Alleles) CYP2C9 CYP2D6 Genotype2

    Add to Reading List

    Source URL: wwwn.cdc.gov

    Language: English - Date: 2013-02-13 14:52:57